Pharma Supplier Achieves $1.25M in Annual Savings and Industry Recognition with Decarbonization Master Planning

Executive summary

A leading pharmaceutical supplier partnered with SSC to develop a comprehensive sustainability strategy. By integrating Decarbonization Master Planning with on-site assessments and greenhouse gas benchmarking, SSC identified over $1.25 million in annual savings while building a scalable framework for emissions management across all facilities. The supplier not only improved operational efficiency but also gained recognition from major pharmaceutical companies for the maturity of its sustainability program. Today, the company is using its program as a competitive advantage, aligning with customer requirements for emissions reporting, reduction, and science-based target setting.

Protecting our clients' data is non-negotiable. This case study has been fully sanitized to safeguard their confidentiality because, at SSC, trust and security are paramount.

 

Key Findings

  1. $1.25M in Annual Savings Identified:
    Through standardizing an annual process for measuring energy consumption and calculating greenhouse gas emissions combined with an on-site operations assessment, SSC uncovered significant efficiency and cost-saving opportunities.

  2. Scalable Sustainability Framework:
    Established company-wide systems for tracking fuel use, utility data, and carbon emissions, enabling consistent performance measurement across all facilities.

  3. Supplier Recognition:
    The client earned credibility with major pharmaceutical customers by demonstrating advanced sustainability practices aligned with global expectations.

  4. Scope 3 Preparedness:
    SSC helped the supplier conduct their Scope 3 analysis, identifying key emissions hotspots and laying the groundwork for future science-based targets. SSC assisted with integration of all GHG data into a software platform.

  5. Competitive Advantage:
    The company’s growing sustainability maturity positioned it as a preferred supplier, supporting both business growth and alignment with big pharma requirements.

 
 

Results

Estimated Annual Savings: $1,250,000

  1. Implementation of a benchmarking and measurement system across all facilities.

  2. Development of a scalable Decarbonization Master Plan focused on energy efficiency and a renewable energy strategy to reduce long-term emissions.

  3. Enhanced supplier credibility with major pharmaceutical companies.

  4. Alignment with customer requirements for Scope 3 emissions reporting and science-based target setting.

 

“Sustainability is now a true business driver for this client and has positioned them as a preferred supplier to major pharmaceutical companies. By incorporating this plan across multiple facilities, they are achieving significant reductions in Scope 1 and Scope 2 emissions while building a consistent framework for long-term impact and continued business growth.”

Tad Radzinski, PE, SEP, LEED AP, SFP

President & Co-Founder, Sustainable Solutions Corporation

 
 

Solutions We Delivered

Decarbonization master plan